CONGRUENCE THERAPEUTICS Trademark

Trademark Overview

On Tuesday, August 10, 2021, a trademark application was filed for CONGRUENCE THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the CONGRUENCE THERAPEUTICS trademark a serial number of 90875011. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Monday, October 27, 2025. This trademark is owned by Congruence Therapeutics Inc.. The CONGRUENCE THERAPEUTICS trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Providing information relating to medical disorders, diagnosis and treatment options, not including addiction treatment, substance abuse, cognitive therapy, psychological counseling or psychotherapy

Scientific and medical research

Pharmaceutical preparations for treating rare diseases, metabolic diseases, and neurodegenerative diseases
congruence therapeutics

General Information

Serial Number90875011
Word MarkCONGRUENCE THERAPEUTICS
Filing DateTuesday, August 10, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateMonday, October 27, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 16, 2023

Trademark Statements

NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesProviding information relating to medical disorders, diagnosis and treatment options, not including addiction treatment, substance abuse, cognitive therapy, psychological counseling or psychotherapy
Goods and ServicesScientific and medical research
Goods and ServicesPharmaceutical preparations for treating rare diseases, metabolic diseases, and neurodegenerative diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, October 1, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, October 1, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, April 12, 2023
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCongruence Therapeutics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWestmount, Quebec H3Y3A7
CA
Party NameCongruence Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWestmount, Quebec H3Y3A7
CA

Trademark Events

Event DateEvent Description
Friday, August 13, 2021NEW APPLICATION ENTERED
Friday, October 1, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 10, 2022ASSIGNED TO EXAMINER
Wednesday, May 11, 2022NON-FINAL ACTION WRITTEN
Wednesday, May 11, 2022NON-FINAL ACTION E-MAILED
Wednesday, May 11, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, September 7, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, September 7, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 8, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 29, 2022SUSPENSION LETTER WRITTEN
Thursday, September 29, 2022LETTER OF SUSPENSION E-MAILED
Thursday, September 29, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, March 9, 2023TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, March 9, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 9, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 12, 2023EXAMINERS AMENDMENT -WRITTEN
Wednesday, April 12, 2023EXAMINERS AMENDMENT E-MAILED
Wednesday, April 12, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, April 12, 2023EXAMINER'S AMENDMENT ENTERED
Wednesday, April 12, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 13, 2023REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, April 26, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 16, 2023PUBLISHED FOR OPPOSITION
Tuesday, May 16, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, May 31, 2023EXTENSION OF TIME TO OPPOSE RECEIVED
Sunday, September 24, 2023EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Tuesday, November 7, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, February 14, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, February 14, 2024SOU EXTENSION 1 FILED
Wednesday, February 14, 2024SOU EXTENSION 1 GRANTED
Thursday, February 15, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 21, 2024SOU TEAS EXTENSION RECEIVED
Monday, October 21, 2024SOU EXTENSION 2 FILED
Monday, October 21, 2024SOU EXTENSION 2 GRANTED
Monday, October 21, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 18, 2025SOU TEAS EXTENSION RECEIVED
Friday, April 18, 2025SOU EXTENSION 3 FILED
Friday, April 18, 2025SOU EXTENSION 3 GRANTED
Saturday, April 19, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 27, 2025SOU TEAS EXTENSION RECEIVED
Monday, October 27, 2025SOU EXTENSION 4 FILED
Monday, October 27, 2025SOU EXTENSION 4 GRANTED
Tuesday, October 28, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

therapeutics congruence diseases medical treatment research scientific psychotherapy counseling pharmaceutical preparations neurodegenerative